Company news
EMV Capital PLC news in 2020
EMV Capital PLC's news releases, calls and decks from 2020, newest first.
PDS Announces Publication of Data by Mount Sinai
December 21, 2020
ProAxsis awarded Innovate UK grant
December 10, 2020
Board changes and Grant of Options
December 2, 2020
EMV Capital leads a £1.28m investment in SageTech
November 30, 2020
ProAxsis appoints DiaPharma as distributor
November 19, 2020
PDS updates on Versamune based COVID-19 vaccine
November 11, 2020
PDS Biotech Initiates VERSATILE-002 Phase 2 Trial
November 10, 2020
PDS Announces Initiation of PDS0101 Phase 2 Trial
October 27, 2020
NetScientific acquires 100% of portfolio company
October 16, 2020
Grant of Options to Director
September 25, 2020
Result of General Meeting
August 24, 2020
PDS Announces Closing of $19m Offering
August 14, 2020
Sofant secures £2.3m funding led by EMV Capital
August 12, 2020
PDS Announces Proposed Offering of Common Stock
August 11, 2020
Posting of shareholder circular
August 7, 2020
Result of Placing
August 5, 2020
PDS Announces Preclinical Data for PDS0203
July 27, 2020
PDS collaborator awarded grant for Versamune
July 14, 2020
G-Tech Medical completes $6.7m Series A financing
June 29, 2020
PDS & Farmacore Announce Co-Development-PDS0204
June 18, 2020
PDS Announces Initiation of Phase 2 Trial PDS0101
June 15, 2020
PDS Announces Trial of its Lead Product, PDS0101
June 5, 2020
PDS Reports Results for Q1 2020 & Business Update
May 13, 2020
Confirmation of Board Changes
May 1, 2020
PDS expands CRADA with National Cancer Institute
April 30, 2020
Preliminary Results for the year ended 31 Dec 2019
April 27, 2020
PDS Initiates Programs for COVID-19, PDS0101 delay
April 16, 2020
PDS Appoints Ilian Iliev to the Board
April 14, 2020
PDS equity issue and related party transaction
February 12, 2020
PDS Biotechnology proposed offering
February 11, 2020